CBColette S.M. Bilynsky

Colette S.M. Bilynsky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Colette S.M. Bilynsky has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Preclinical Evidence Synthesis Facilitates Open Science

    by Colette Bilynsky

    Evidence synthesis methodology, particularly preclinical evidence synthesis reviews, provides substantial benefits by reducing research waste, enhancing the quality of research, and providing comprehensive and objective overviews of specific fields. These reviews also allow for the contribution of citizen scientists, who represent an important facet of open science. Recent policy changes by the Biden-Harris Administration require that researchers receiving federal funding immediately make their publications and data available to the public without an embargo, highlighting the importance placed upon the open science principles of transparency, reproducibility, and accessibility. Despite this, the following assessment highlights two challenges for evidence synthesis reviews that are at odds with open science principles: (1) the lack of funding available for evidence synthesis reviews, particularly preclinical reviews, despite their demonstrated value and (2) the slow and expensive traditional publication model. I recommend allocating funding for preclinical evidence synthesis reviews as they are beneficial to both the researchers conducting the review and the field that is being reviewed. I also recommend supporting publication platforms that employ the quick release of preprints with a transparent peer review process and/or creating a federally funded and run publication platform characterized by open access and minimal publication costs.


  • Open Access

    Meta-analysis of macrophage nanoparticle targeting across blood and solid tumors using an eLDA Topic modeling Machine Learning approach

    by Chloe Brown, Colette S.M. Bilynsky, Melanie Gainey, Sarah Young, John Kitchin, Elizabeth C Wayne

    The role of macrophages in regulating the tumor microenvironment has spurned the exponential generation of nanoparticle targeting technologies. With the large amount of literature and the speed at which it is generated it is difficult to remain current with the most up-to-date literature. In this study we performed a topic modeling analysis of the most common usages of nanoparticle targeting of macrophages in solid tumors. The data spans 20 years of literature, providing an extensive meta-analysis of the nanoparticle strategies. Our topic model found 6 distinct topics: Immune and TAMs, Nanoparticles, Imaging, Gene Delivery and Exosomes, Vaccines, and Multi-modal Therapies. We also found distinct nanoparticle usage, tumor types, and therapeutic trends across these topics. Moreover, we established that the topic model could be used to assign new papers into the existing topics, thereby creating a Living Review. This type of meta-analysis provides a useful assessment tool for aggregating data about a large field.

  • Open Access

    Nanoparticle endocytosis is driven by monocyte phenotype rather than nanoparticle size under high shear flow conditions

    by Dasia A. Aldarondo, Chris Huynh, Leah Dickey, Colette S.M. Bilynsky, Yerim Lee, Elizabeth C. Wayne

    Monocytes are members of the mononuclear phagocyte system involved in pathogen clearance and nanoparticle pharmacokinetics. Monocytes play a critical role in the development and progression of cardiovascular disease and, recently, in SARS-CoV-2 pathogenesis. While studies have investigated the effect of nanoparticle modulation on monocyte uptake, their capacity for nanoparticle clearance is poorly studied. In this study, we investigated the impact of ACE2 deficiency, frequently observed in individuals with cardiovascular complications, on monocyte nanoparticle endocytosis. Moreover, we investigated nanoparticle uptake as a function of nanoparticle size, physiological shear stress, and monocyte phenotype. Our Design of Experiment (DOE) analysis found that the THP-1 ACE2 - cells showed a greater preference for 100nm particles under atherosclerotic conditions than THP-1 wild-type cells. Observing how nanoparticles can modulate monocytes in the context of disease can inform precision dosing.


  • Open Access

    TCID50 Measurements of anti-viral efficacy on metal printed masks and plastic surfaces

    by Colette S.M. Bilynsky, Kishana Taylor, Megha Anand, Elizabeth Wayne

    The SARS-CoV-2 pandemic has created a need for effective personal protective equipment (PPE) to prevent viral spread. PPE like face masks contain the spread of virus-filled droplets and thus reduce infection rates, has been a critical tool in stopping the spread of SARS-CoV-2. PET plastic barriers have also been used in public settings to reduce face to face viral transmission. However, in some cases, they have provided additional contact with the virus due to contamination. In order study, we evaluated the effectiveness of face masks and PET plastics coated in different metals in reducing viral load. We compared PPE printed with silver, copper, or zinc for their ability to inactivate live human coronavirus HCoV 229E. Our results show that silver and copper have significant anti-viral efficacy when printed on nonwoven fabric compared to the controls. The metal-printed PET showed around 70% anti-viral efficacy with any formulations, with copper performing the best. This work builds more data to support the development of metal printed materials for enhanced protection against coronaviruses.